33
/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
7975116
757069
2

jan 1, 2007 - Food and Drug Administration Amendments Act of 2007

Description:

Specifically authorized FDA to require manufacturers post-marketing clinical studies to monitor for risks infected during the pre-market approval process
Also required REMS programs where necessary. What is a REMS program?

Added to timeline:

Date:

jan 1, 2007
Now
~ 18 years ago